Ahmad Shamabadi

16PUBLICATIONS
18CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Microbial ecologyAdolescent healthNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 23, 2026
Rosiglitazone Adjunct to Sertraline for Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.

|May 24, 2026
Pharmacotherapeutic Management of Depression in Patients With Cancer: A Review of Mechanistic and Clinical Evidence.

|Apr 10, 2026
The gut-brain axis and inflammatory mediators in suicide and mental disorders with high suicide rates: a review of current evidence.

Ahmad Shamabadi, Razman Arabzadeh Bahri, Melika Arab Bafrani

|Dec 26, 2025
Rosiglitazone Adjunct to Risperidone for Irritability in Autistic Children: A Randomized, Double-Blind, Placebo-Controlled Trial.

Nikoo Bayan, Negar Bayan, Faezeh Mokhtari

|Oct 02, 2024
Naproxen adjunct to fluoxetine for moderate-to-severe obsessive-compulsive disorder: A randomized, double-blind, placebo-controlled trial.

Ahmad Shamabadi, Zahra Motavalian, Yalda Farahmand

|May 08, 2024
Emerging pharmacotherapy for the treatment of cannabis use disorder.

Ahmad Shamabadi, Razman Arabzadeh Bahri, Hanie Karimi

Pageof 3

Frequent Collaborators

8 joint publications

Shahin Akhondzadeh

4 joint publications

Hanie Karimi

3 joint publications

Razman Arabzadeh Bahri

2 joint publications

Seyed Mohammad Javad Mortazavi